Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: Apixaban 5 MG [Eliquis]
Total 0 results
Nothing found
Sponsors and Collaborators
Stefano Rizza
IRCCS San Raffaele Roma
Gynea Laboratorios SA
Universidad de Chile (UChile, Chile)
Washington State Attorney General's Office
Peijas Hospital
Advanced Reconstructive Surgery Alliance
Hangzhou Neoantigen Therapeutics Co., Ltd.
WillowWood Global LLC
Pedro Rodrigues Genta
Center for HIV/AIDS Vaccine Immunology
London Metropolitan University
Nuseed Americas Inc.
Dermatologic Surgery Center of Washington LLC and Skin Cancer Treatment Center
Marealis AS
Hoffmann-La Roche
delta medical promotions ag
HMO Gesundheitsplan Basel, Switzerland
mHealth Impact Lab
the Regional Direction of Clinical Research
View Full List
Medical Conditions
Low-dose Corticosteroids Pretreatment
Infantile GM2 Gangliosidosis (Disorder)
Peroxisomal Disorders
Urticaria Chronic
Shoulder Arthroscopy Blocks
Delivery
Mitochondrial DNA Mutation
Type D Personality
Retinal Surgery
Perforation of Eardrum.
Congenital Heart Disease in Children
Deep Hypothermic Circulatory Arrest
Neoplasms, Urethral
Mindfulness-based Intervention
Adult Oligoastrocytoma
Hypopigmented Skin
Depressive; Disorder, Major, Single Episode, Major, With Psychotic Symptoms
Orthopedics
Philadelphia Chromosome
The Angle of Trunk Rotation in Thoracic Part
View Full List
Drug Interventions
Immediate-release nicotinamide (SAD)
Etoposide
BIC/FTC/TAF
Delamanid
RhGM-CSF
Basiliximab
Ibrutinib
Silymarin (Silybum marianum)
Atorvastatin
MP0317, a tri-specific fibroblast activation protein (FAP) x CD40 DARPin® drug candidate (q1w regimen)
Active Comparator: TU2670 320mg
Metronidazole
Amivantamab
Neridronate
Simvastatin
Fosinopril sodium and hydrochlorothiazide 20-12.5 mg tablets
Vincristine
Yohimbine hydrochloride
Rituxumab
Bictegravir (BIC) plus Emtricitabine (FTC) plus Tenofovir Alafenamide (TAF)
View Full List
CROs by country
Contract Research Organizations in Albania
Contract Research Organizations in Austria
Contract Research Organizations in Bahamas
Contract Research Organizations in Belgium
Contract Research Organizations in Djibouti
Contract Research Organizations in Finland
Contract Research Organizations in Iran
Contract Research Organizations in Malawi
Contract Research Organizations in Mongolia
Contract Research Organizations in Taiwan
Contract Research Organizations in Tunisia
Contract Research Organizations in Uruguay
Contract Research Organizations in Zambia
CRO list by country
CROs in Uruguay
Estudios Clínicos Latinoamérica (ECLA)
TRIO
Raras CRO
SGS
ACROSS Global
All CROs in Uruguay
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe